The Women Tennis Association, through an official statement, has shown its full support for Iga Swiatek.
Last August, the Polish player failed a doping control for the prohibited substance trimetazidine (TMZ) and accepted the one-month ban decided by the ITIA.
According to what was communicated by the ITIA, the positive result is linked to the contamination of a non-prescription drug (melatonin) in Poland and therefore the violation was not intentional. Swiatek will have to respect a one-month ban, but she had already been provisionally suspended from September 22 to October 4. She therefore has only eight days left to serve.
Below you can read the official WTA statement:
“The WTA acknowledges the decision of the International Tennis Integrity Association (ITIA), which administers the Tennis Anti-Doping Program (TADP), to suspend Iga Swiatek for one month, following the identification of a contaminated regulated drug (melatonin) as the source of her positive test for the prohibited substance Trimetazidine.
The WTA fully supports Iga at this difficult time. Iga has consistently demonstrated a strong commitment to fair play and the principles of clean sport, and this unfortunate incident highlights the…
